NASDAQ: IRIX
Iridex Corp Stock Ownership - Who owns Iridex?

Insider buying vs selling

Have Iridex Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Romeo R. DizonChief Financial Officer2025-09-04625$1.39
$868.75Buy
Romeo R. DizonChief Financial Officer2025-09-0496$1.35
$129.12Buy
Romeo R. DizonChief Financial Officer2025-09-04404$1.32
$533.28Buy
Romeo R. DizonChief Financial Officer2025-09-03625$1.36
$850.00Buy
Romeo R. DizonChief Financial Officer2025-09-02625$1.34
$837.50Buy
Romeo R. DizonChief Financial Officer2025-08-29625$1.37
$856.25Buy
Romeo R. DizonChief Financial Officer2025-08-28250$1.35
$337.50Buy
Romeo R. DizonChief Financial Officer2025-08-2850$1.33
$66.50Buy
Romeo R. DizonChief Financial Officer2025-08-28505$1.36
$686.80Buy
Romeo R. DizonChief Financial Officer2025-08-28200$1.33
$265.00Buy

1 of 9

IRIX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IRIX insiders and whales buy or sell their stock.

IRIX Shareholders

What type of owners hold Iridex Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blueline Catalyst Fund IX LP15.06%2,559,122$3.38MInsider
Blueline Capital Partners II LP14.76%2,508,100$3.31MInsider
Blueline Partners LLC 114.62%2,483,815$3.28MInsider
Blueline Partners LLC14.51%2,465,222$3.25MInsider
Scott Shuda10.30%1,750,059$2.31MInsider
Topcon America Corp9.52%1,618,122$2.14MInsider
Associates Paragon Associates Ii Joint Venture Paragon7.77%1,320,000$1.74MInsider
Acuta Capital Fund LP6.81%1,157,011$1.53MInsider
Blueline Capital Partners LP6.70%1,138,862$1.50MInsider
Paragon Associates Paragon Associates II Joint Venture5.89%1,000,000$1.32MInstitution

1 of 3

IRIX vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IRIX12.19%87.81%Net BuyingNet Buying
ADGM53.92%46.08%
NSYS2.60%97.40%Net Buying
COCH50.10%49.90%Net BuyingNet Buying
IINN0.62%0.00%

Iridex Stock Ownership FAQ

Who owns Iridex?

Iridex (NASDAQ: IRIX) is owned by 15.83% institutional shareholders, 114.03% Iridex insiders, and 0.00% retail investors. Blueline Catalyst Fund IX LP is the largest individual Iridex shareholder, owning 2.56M shares representing 15.06% of the company. Blueline Catalyst Fund IX LP's Iridex shares are currently valued at $3.58M.

If you're new to stock investing, here's how to buy Iridex stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.